Recently, upregulation of SREBP2 and HMGCR resulting in increased serum LDL-C, and accumulating hepatic free cholesterol and LDL-C was related to the pathogenesis and progression of human NAFLD [31]. The gene discussed is SREBF2; the disease is metabolic dysfunction-associated steatotic liver disease.